MEDIKAMENT ZUR MALIGNOMBEHANDLUNG

European patent · EP3586132 · In force

Register entry

Publication number
EP3586132
Application number
EP18707335
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 22, 2018
Published
Jan 1, 2020
Granted
Jun 7, 2023
Protection ends at the latest
Feb 21, 2038
Next annual fee due
Feb 28, 2027
IPC classes
G01N 33/50 (2006.01)
G01N 33/569 (2006.01)
C07K 16/28 (2006.01)
A61K 39/395 (2006.01)
Priority
DE 102017001875 27.02.2017
PCT application
PCT/EP2018/054339 22.02.2018
PCT publication
WO2018/153956 30.08.2018
Filing language
German
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 1, 2026

    Change

    Published in Swissreg on 01.03.2026

  2. Mar 1, 2025

    Change

    Published in Swissreg on 01.03.2025

  3. Apr 24, 2024

    Change

    Published in Swissreg on 24.04.2024

  4. Apr 17, 2024

    Change

    Published in Swissreg on 17.04.2024

  5. Mar 1, 2024

    Change

    Published in Swissreg on 01.03.2024

  6. Sep 6, 2023

    Agent entered

    Representative
    BUGNION SA, route de Florissant 10, 1206 Genève

    Published in Swissreg on 06.09.2023

  7. Jun 7, 2023

    Granted

    Published in Swissreg on 07.06.2023

Parties

Holder

Intellexon GmbH

Keltenstraße 27, 82343 Pöcking, DE

Agent

Bugnion SA

BUGNION SA

route de Florissant 10, 1206 Genève

Inventor

WÜRFEL, Wolfgang

85235 Sixtnitgern, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.